Table 1.
Development in COVID-19 relevant biochemical parameters during first hospital stay.
| Analysis | Unit | Week of First Hospital Stay | Reference Interval | ||
|---|---|---|---|---|---|
| 1 | 2 | 3 | |||
| Hemoglobin | g/dL | 11.8 | 11.4 | 10.5 | 11.7–15.3 |
| Total leukocytes | ×109/L | 5.0 | 5.3 | 6.1 | 4.1–9.8 |
| Neutrophils | ×109/L | 3.7 | 3.7 | 3.9 | 1.8–6.9 |
| Lymphocytes | ×109/L | 0.8 | 1.0 | 1.3 | 1.2–3.1 |
| Monocytes | ×109/L | 0.49 | 0.57 | 0.83 | 0.28–0.90 |
| Eosinophils | ×109/L | 0.0 | 0.0 | 0.1 | ≤0.5 |
| Basophils | ×109/L | 0.01 | 0.02 | 0.03 | ≤0.10 |
| Thrombocytes | ×109/L | 224 | 346 | 591 | 165–387 |
| CRP | mg/L | 13 | 34 | 34 | <5 |
| Interleukin-6 | ng/L | 32 | 53 | 28 | 0–7 |
| Procalcitonin | µg/L | <0.10 | <0.10 | 0.13 | <0.10 |
| Ferritin | µg/L | 65 | 92 | 215 | 18–240 |
| PT-INR | ₋ | 0.9 | 1.0 | 0.9 | 0.9–1.2 |
| APTT | s | 24 | 26 | ₋ | 22–30 |
| Fibrinogen | g/L | 4.8 | 5.1 | ₋ | 1.9–4.0 |
| D-dimer | mg/L FEU | 1.05 | 1.3 | ₋ | <0.27 |
| ALAT | U/L | 17 | 86 | 303 | 10–45 |
| ASAT | U/L | 35 | 71 | 227 | 15–35 |
| ALP | U/L | 82 | 80 | 161 | 35–105 |
| LD | U/L | 228 | 195 | 295 | 105–205 |
Abbreviations: CRP—C-Reactive Protein, PT-INR—Prothrombin-International Normalized Ratio, APTT—Activated Partial Thromboplastin Time, ALAT—Alanine Aminotransferase ASAT—Aspertate Aminotransferase, ALD—alkaline phosphatase, LD—lactate dehydrogenase, FEU—fibrinogen equivalent units.